Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase

Journal of Immunology

Volumn 184, Issue 3, 2010, Pages 1419-1424

  Dolan, Brian P ^a   Li, Lily ^a   Takeda, Kazuyo ^a   Bennink, Jack R ^a   Yewdell, Jonathan W ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PEPTIDE; PROTEASOME; SERYLISOLEUCYLISOLEUCYLASPARAGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; SIALIDASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; EPITOPE; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; OVA 8; OVA-8; OVALBUMIN; PEPTIDE FRAGMENT; RIBOSOME PROTEIN; VIRUS ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BIOSYNTHESIS; CELL SURFACE; CONTROLLED STUDY; DENDRITIC CELL; FIBROBLAST; FLOW CYTOMETRY; INFLUENZA; INFLUENZA VIRUS A; INHIBITION KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RIBOSOME; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; DOG; ENZYME ACTIVATION; ENZYME STABILITY; ENZYMOLOGY; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; L CELL; METABOLISM; MOLECULAR GENETICS; ORTHOMYXOVIRUS INFECTION; PHYSIOLOGY; SECRETION; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CELL LINE; DENDRITIC CELLS; DOGS; ENZYME ACTIVATION; ENZYME STABILITY; EPITOPES; FIBROBLASTS; H-2 ANTIGENS; INFLUENZA A VIRUS, H1N1 SUBTYPE; L CELLS (CELL LINE); MICE; MOLECULAR SEQUENCE DATA; MONOCYTES; NEURAMINIDASE; ORTHOMYXOVIRIDAE INFECTIONS; OVALBUMIN; PEPTIDE FRAGMENTS; PROTEIN BIOSYNTHESIS; PROTEIN FOLDING; PROTEIN TRANSPORT; RIBOSOMAL PROTEINS;

EID: 77949317182     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901907     Document Type: Article

References (31)

1. Esquivel, F., J. Yewdell, and J. Bennink. 1992. RMA/S cells present endogenously synthesized cytosolic proteins to class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 175: 163-168.
2. Yewdell, J. W., L. C. Antón, and J. R. Bennink. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J. Immunol. 157: 1823-1826.
3. Qian, S. B., M. F. Princiotta, J. R. Bennink, and J. W. Yewdell. 2006. Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J. Biol. Chem. 281: 392-400.
4. Wheatley, D. N., M. R. Giddings, and M. S. Inglis. 1980. Kinetics of degradation of "short-" and "long-lived" proteins in cultured mammalian cells. Cell Biol. Int. Rep. 4: 1081-1090.
5. Schubert, U., L. C. Antón, J. Gibbs, C. C. Norbury, J. W. Yewdell, and J. R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404: 770-774. (Pubitemid 30212405)
6. Vabulas, R. M., and F. U. Hartl. 2005. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 310: 1960-1963.
7. Yewdell, J. W. 2007. Plumbing the sources of endogenous MHC class I peptide ligands. Curr. Opin. Immunol. 19: 79-86.
8. Qian, S. B., E. Reits, J. Neefjes, J. M. Deslich, J. R. Bennink, and J. W. Yewdell. 2006. Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J. Immunol. 177: 227-233.
9. Reits, E. A., J. C. Vos, M. Grommé, and J. Neefjes. 2000. The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature 404: 774-778.
10. Khan, S., R. de Giuli, G. Schmidtke, M. Bruns, M. Buchmeier, M. van den Broek, and M. Groettrup. 2001. Cutting edge: neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein. J. Immunol. 167: 4801-4804. (Pubitemid 33009706)
11. Princiotta, M. F., D. Finzi, S. B. Qian, J. Gibbs, S. Schuchmann, F. Buttgereit, J. R. Bennink, and J. W. Yewdell. 2003. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18: 343-354.
12. Berglund, P., D. Finzi, J. R. Bennink, and J. W. Yewdell. 2007. Viral alteration of cellular translational machinery increases defective ribosomal products. J. Virol. 81: 7220-7229. (Pubitemid 46986658)
13. Neumeister, C., R. Nanan, T. I. Cornu, C. G. K. Lüder, V. ter Meulen, H. Naim, and S. Niewiesk. 2001. Measles virus and canine distemper virus target proteins into a TAP-independent MHC class I-restricted antigen-processing pathway. J. Gen. Virol. 82: 441-447.
14. Johnstone, C., S. Guil, M. A. Rico, B. García-Barreno, D. López, J. A. Melero, and M. Del Val. 2008. Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes. J. Gen. Virol. 89: 2194-2203.
15. Yen, H. C., Q. Xu, D. M. Chou, Z. Zhao, and S. J. Elledge. 2008. Global protein stability profiling in mammalian cells. Science 322: 918-923.
16. Lev, A., K. Takeda, D. Zanker, J. C. Maynard, P. Dimberu, E. Waffarn, J. Gibbs, N. Netzer, M. F. Princiotta, L. Neckers, et al. 2008. The exception that reinforces the rule: crosspriming by cytosolic peptides that escape degradation. Immunity 28: 787-798.
17. + T cell immunodominance hierarchies when antigen is limiting. J. Immunol. 177: 2917-2925.
18. Mintern, J. D., S. Bedoui, G. M. Davey, J. M. Moffat, P. C. Doherty, and S. J. Turner. 2009. Transience of MHC class I-restricted antigen presentation after influenza A virus infection. Proc. Natl. Acad. Sci. USA 106: 6724-6729.
19. Yewdell, J. W., A. Yellen, and T. Bächi. 1988. Monoclonal antibodies localize events in the folding, assembly, and intracellular transport of the influenza virus hemagglutinin glycoprotein. Cell 52: 843-852.
20. Hausmann, J., E. Kretzschmar, W. Garten, and H. D. Klenk. 1997. Biosynthesis, intracellular transport and enzymatic activity of an avian influenza A virus neuraminidase: role of unpaired cysteines and individual oligosaccharides. J. Gen. Virol. 78: 3233-3245.
21. Doms, R. W., G. Russ, and J. W. Yewdell. 1989. Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J. Cell Biol. 109: 61-72.
22. van Hall, T., J. van Bergen, P. A. van Veelen, M. Kraakman, L. C. Heukamp, F. Koning, C. J. Melief, F. Ossendorp, and R. Offringa. 2000. Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin. J. Immunol. 165: 869-877.
23. Reits, E., A. Griekspoor, J. Neijssen, T. Groothuis, K. Jalink, P. van Veelen, H. Janssen, J. Calafat, J. W. Drijfhout, and J. Neefjes. 2003. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18: 97-108.
24. Shaffer, A. L., M. Shapiro-Shelef, N. N. Iwakoshi, A. H. Lee, S. B. Qian, H. Zhao, X. Yu, L. Yang, B. K. Tan, A. Rosenwald, et al. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21: 81-93.
25. Ostankovitch, M., V. Robila, and V. H. Engelhard. 2005. Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. J. Immunol. 174: 2544-2551.
26. Ostankovitch, M., M. Altrich-Vanlith, V. Robila, and V. H. Engelhard. 2009. N-glycosylation enhances presentation of a MHC class I-restricted epitope from tyrosinase. J. Immunol. 182: 4830-4835.
27. Skipper, J. C. A., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wolfel, C. L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from post-translational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183: 527-534.
28. Bacik, I., H. L. Snyder, L. C. Antón, G. Russ, W. Chen, J. R. Bennink, L. Urge, L. Otvos, B. Dudkowska, L. Eisenlohr, and J. W. Yewdell. 1997. Introduction of a glycosylation site into a secreted protein provides evidence for an alternative antigen processing pathway: transport of precursors of major histocompatibility complex class I-restricted peptides from the endoplasmic reticulum to the cytosol. J. Exp. Med. 186: 479-487.
29. Schlosser, E., C. Otero, C. Wuensch, B. Kessler, M. Edelmann, R. Brunisholz, I. Drexler, D. F. Legler, and M. Groettrup. 2007. A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteins. EMBO Rep. 8: 945-951.
30. Yewdell, J. 2002. To DRiP or not to DRiP: generating peptide ligands for MHC class I molecules from biosynthesized proteins. Mol. Immunol. 39: 139-146.
31. Yewdell, J. W., and C. V. Nicchitta. 2006. The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol. 27: 368-373.